Ely Benaim - Jul 5, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Medical Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ely Benaim
Stock symbol
NVCR
Transactions as of
Jul 5, 2022
Transactions value $
$13,115
Form type
4
Date filed
7/7/2022, 05:47 PM
Previous filing
May 12, 2022
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $13.1K +222 +0.64% $59.08 35.1K Jul 5, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.